| ICD-10-CM-2023 > G00-G99 > G70-G73 > G70 |
G70-G73 | Diseases of myoneural junction and muscle | |
G70 | Myasthenia gravis and other myoneural disorders | |
Excl1.: | botulism (A05.1, A48.51-A48.52) transient neonatal myasthenia gravis (P94.0) | |
G70.0 | Myasthenia gravis | |
G70.00 | Myasthenia gravis without (acute) exacerbation | |
Info: | Myasthenia gravis NOS | |
G70.01 | Myasthenia gravis with (acute) exacerbation | |
Info: | Myasthenia gravis in crisis | |
G70.1 | Toxic myoneural disorders | |
Code first | (T51-T65) to identify toxic agent | |
G70.2 | Congenital and developmental myasthenia | |
G70.8 | Other specified myoneural disorders | |
G70.80 | Lambert-Eaton syndrome, unspecified | |
Info: | Lambert-Eaton syndrome NOS | |
G70.81 | Lambert-Eaton syndrome in disease classified elsewhere | |
Code first | underlying disease | |
Excl1.: | Lambert-Eaton syndrome in neoplastic disease (G73.1) | |
G70.89 | Other specified myoneural disorders | |
G70.9 | Myoneural disorder, unspecified | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |